Home News Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations back to News
minute read
“Medicare will begin negotiating prices for top-selling drugs in 2023, but since the United States does not have a public health technology assessment entity that determines comparative effectiveness, the Centers for Medicare & Medicaid Services will need to conduct its own assessments for the drugs being negotiated," said Michael J. DiStefano, PhD.
Topics: Press Coverage, Pharmacy, Clinical Research
12850 East Montview Boulevard
Aurora, CO 80045
303-724-2882
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
